Skip to main content

Table 4 Summary of the FLR changes

From: Rescue radiofrequency ablation or percutaneous ethanol injection: a strategy for failed RALPPS stage-1 in patients with cirrhosis-related hepatocellular carcinoma

Variable

Median (range)

Baseline

 FLR, ml

339 (225–420)

 FLR, %

26 (19–33)

First week after RALPPS stage-1

 KGR, ml/day

17.8 (− 1.2–31.7)

 KGR, %/week

10 (− 1–15)

Second week after RALPPS stage-1

 KGR, ml/day

3 (0.4–16.3)

 KGR, %/week

1.5 (0–9)

Before rescue procedures

 KGR, ml/day

2.0 (0.3–4.8)

 KGR, %/week

1 (0–3)

After rescue procedures

 KGR, ml/day

6.3 (4.2–9.6)

 KGR, %/week

4 (2–5)

 Interval period, daysa

27 (21–32)

Before RALPPS stage-2a

 FLR, ml

505 (452–597)

 FLR, %

41% (40–47%)

Increase ratea

 FLR, ml

227 (143–264)

 FLR, %

101% (36–113%)

 KGR, ml/day

9.4 (5.7–9.9)

 KGR, %/day

3.9 (1.4–4.4)

Completion rate

5/7 (71%)

  1. FLR, future liver remnant; KGR, kinetic growth rate; RALPPS, radiofrequency-assisted ALPPS (associating liver partition and portal vein ligation for staged hepatectomy); aFive patients completed RALPPS stage-2